NCT06952465 2025-05-01
A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
Bristol-Myers Squibb
Active not recruiting
Bristol-Myers Squibb
Akdeniz University
University of California, San Diego
University of California, San Diego